eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Arteriovenous Fistulae, Pulmonary: Differential Diagnoses & Workup

Author: Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St. Boniface General Hospital
Contributor Information and Disclosures

Updated: Apr 28, 2009

Differential Diagnoses

Atrial Septal Defect, Coronary Sinus
Partial Anomalous Pulmonary Venous Connection
Atrial Septal Defect, General Concepts
Patent Ductus Arteriosus
Congenital Arterial and Venous Anomalies: Surgical Perspective
Pulmonary Hypertension, Eisenmenger Syndrome
Ebstein Anomaly
Respiratory Failure
Ebstein Malformation: Surgical Perspective
Schistosomiasis
Hemothorax
Ventricular Septal Defect, General Concepts
Osler-Weber-Rendu Syndrome
Partial and Total Anomalous Pulmonary Venous Connection: Surgical Perspective

Other Problems to Be Considered

Consider the diagnosis of pulmonary arteriovenous malformations (PAVM) in individuals with any of the following presentations: (1) 1 or more pulmonary nodules associated with typical chest radiographic findings of pulmonary arteriovenous malformations; (2) mucocutaneous telangiectases; (3) unexpected findings such as dyspnea, hemoptysis, hypoxemia, polycythemia, clubbing, cyanosis, cerebral embolism, or brain abscess.

Workup

Laboratory Studies

  • Patients may have anemia because of the ongoing blood loss caused by arteriovenous malformations (AVMs) in the GI tract.
  • However, hypoxemic patients without GI bleeding is usually present with polycythemia.

Imaging Studies

  • Chest radiography (see Media files 2-3, Media files 7-8)

    Left lower lobe arteriovenous malformation (AVM).

    Left lower lobe arteriovenous malformation (AVM).

    Left lower lobe arteriovenous malformation (AVM).

    Left lower lobe arteriovenous malformation (AVM).


    Lateral radiograph showing a left lower lobe arte...

    Lateral radiograph showing a left lower lobe arteriovenous malformation (AVM).

    Lateral radiograph showing a left lower lobe arte...

    Lateral radiograph showing a left lower lobe arteriovenous malformation (AVM).


    Small arteriovenous malformations (AVMs) in the r...

    Small arteriovenous malformations (AVMs) in the right and left lower lobes.

    Small arteriovenous malformations (AVMs) in the r...

    Small arteriovenous malformations (AVMs) in the right and left lower lobes.


    Lateral radiograph shows a left lower lobe arteri...

    Lateral radiograph shows a left lower lobe arteriovenous malformation (AVM).

    Lateral radiograph shows a left lower lobe arteri...

    Lateral radiograph shows a left lower lobe arteriovenous malformation (AVM).


    • Chest radiographs reveal some abnormality in approximately 98% of patients. The classic abnormal radiographic finding is a round or oval mass of uniform opacity. The mass is frequently lobulated and most commonly appears in the lower lobes. A chest radiograph can reveal features that may be undetectable on plain chest radiographs; examples include a feeding vessel, an artery radiating from the hilus, and the vein deviating toward the left atrium.
    • In a patient who has clinical features suggestive of pulmonary arteriovenous malformation but normal chest radiographic findings, further evaluation with other modalities should be performed. Patients with microscopic pulmonary arteriovenous malformations may have normal chest radiographic findings. Pulmonary arteriovenous malformations should also be considered in the differential diagnosis of a pulmonary nodule. A cautious approach to these patients is suggested before diagnostic needle biopsy is undertaken.
  • Contrast-enhanced CT scanning (Media files 4-5, Media files 9-12)

    Large left lower lobe arteriovenous malformation ...

    Large left lower lobe arteriovenous malformation (AVM) showing a feeding vessel to the left atrium.

    Large left lower lobe arteriovenous malformation ...

    Large left lower lobe arteriovenous malformation (AVM) showing a feeding vessel to the left atrium.


    Another view of the infused CT scan of the left l...

    Another view of the infused CT scan of the left lower lobe arteriovenous malformation (AVM) shown in Media file 4.

    Another view of the infused CT scan of the left l...

    Another view of the infused CT scan of the left lower lobe arteriovenous malformation (AVM) shown in Media file 4.


    Contrast-enhanced CT scan showing a left lower lo...

    Contrast-enhanced CT scan showing a left lower lobe arteriovenous malformation (AVM).

    Contrast-enhanced CT scan showing a left lower lo...

    Contrast-enhanced CT scan showing a left lower lobe arteriovenous malformation (AVM).


    Right lower lobe arteriovenous malformation (AVM).

    Right lower lobe arteriovenous malformation (AVM).

    Right lower lobe arteriovenous malformation (AVM).

    Right lower lobe arteriovenous malformation (AVM).


    CT scan obtained after coil embolotherapy.

    CT scan obtained after coil embolotherapy.

    CT scan obtained after coil embolotherapy.

    CT scan obtained after coil embolotherapy.


    Left lower lobe embolotherapy performed at the sa...

    Left lower lobe embolotherapy performed at the same sitting as the coil embolotherapy depicted in Media file 11.

    Left lower lobe embolotherapy performed at the sa...

    Left lower lobe embolotherapy performed at the same sitting as the coil embolotherapy depicted in Media file 11.


    • The presence of a pulmonary arteriovenous malformation and its vascular anatomy can also be evaluated by means of contrast-enhanced ultra-fast CT. CT allows for the detection of 90% of pulmonary arteriovenous malformations, whereas, in one study, angiography allowed for the detection of only 60% of pulmonary arteriovenous malformations. The superior sensitivity of CT is attributed to the absence of superimposition of lesions on CT views.
    • Three-dimensional (3D) helical CT scanning produces images of vascular structures that are continuously reconstructed by a helical CT scanner. The accuracy of 3D helical CT scanning is reported to be 95%.
  • Tests for confirmation of an intrapulmonary right-to-left shunt
    • These tests should be performed initially. The shunt is best calculated by using the 100% oxygen method. Contrast echocardiography and radionuclide scanning have nearly 100% sensitivity and are used to confirm clinically significant pulmonary arteriovenous malformations. However, the 100% oxygen method for shunt calculation is the least expensive and readily available.
    • In patients who have a shunt fraction of more than 5%, as determined with the 100% oxygen method, further assessment and management is recommended. In some patients with a shunt fraction of less than 5% but a high clinical suspicion for pulmonary arteriovenous malformations, additional evaluation with contrast echocardiography or radionuclide scanning is recommended.
  • Contrast echocardiography
    • Contrast echocardiography is an excellent tool for evaluating cardiac or intrapulmonary shunts. This technique involves the injection of 5-10 mL of agitated saline into a peripheral vein while simultaneously imaging the right and left atria with 2-dimensional echocardiography. In patients without right-to-left shunting, contrast is rapidly visualized in the right atrium and then gradually dissipates. In patients with intracardiac shunts, contrast is visualized in the left heart chambers within 1 cardiac cycle, after its appearance in the right atrium. In patients with pulmonary arteriovenous malformations, contrast is visualized in the left atrium after a delay of 3-8 cardiac cycles. Contrast echocardiography is almost 100% sensitive in detecting clinically important pulmonary arteriovenous malformations.
    • In one case series, pulmonary arteriovenous malformations were visible in 11 of 14 patients with positive contrast echocardiographic findings who underwent pulmonary angiography. Six had abnormal chest radiographic results, and 8 had an increased A-a gradient. Contrast echocardiography had 100% sensitivity in this study. The finding of an intrapulmonary shunt by means of contrast echocardiography warrants further evaluation with standard pulmonary angiography or contrast-enhanced CT scanning.
  • Radionuclide perfusion lung scanning
    • Radionuclide perfusion lung scanning is also useful in the diagnosis of pulmonary arteriovenous malformations, particularly if contrast echocardiography is not available.
    • In patients without an intrapulmonary shunt, the peripheral intravenous injection of technetium 99m–labeled macroaggregated albumin results in the filtering of these particles by the lung capillaries. However, anatomic shunts with dilated pulmonary vascular channels allow these particles to pass through the lung, with subsequent filtering by the capillaries in the brain and kidneys.
  • Pulmonary angiography (see Media file 6)8

    Pulmonary angiographic findings are required not ...

    Pulmonary angiographic findings are required not only to confirm the diagnosis but also to plan therapeutic embolization.

    Pulmonary angiographic findings are required not ...

    Pulmonary angiographic findings are required not only to confirm the diagnosis but also to plan therapeutic embolization.


    • Despite advances in noninvasive diagnostic techniques, contrast-enhanced pulmonary angiography remains the criterion standard in the diagnosis of pulmonary arteriovenous malformations. This test is usually necessary if embolotherapy is being considered. Perform pulmonary angiography in all lobes of the lungs to look for unsuspected pulmonary arteriovenous malformations.
    • Currently, digital subtraction angiography appears to be replacing conventional angiography. Whether CT or MRI can replace standard pulmonary angiography in the diagnosis of pulmonary arteriovenous malformations requires further comparative studies. Presently, CT and MRI are appropriate noninvasive modalities for the follow-up evaluation of patients with proven pulmonary arteriovenous malformations.
  • MRI: MRI has been reported to be useful in the diagnosis of pulmonary arteriovenous malformations. Rapidly flowing blood results in an absent or minimal MR signal, a so-called flow void. However, pulmonary arteriovenous malformations may be indistinguishable from adjacent air-filled lungs on MRI, a significant limitation in screening for small lesions. Therefore, spin-echo MRI has reduced sensitivity and specificity for detection of pulmonary arteriovenous malformations, compared with those of other techniques. Better results are obtained with phase-contrast cine sequences, and MR angiography can be used to define the vascular anatomy of a pulmonary arteriovenous malformations. A combination of MR techniques may be useful in differentiating pulmonary arteriovenous malformations from various other lesions, but more comparative data are required before the routine use of MRI is recommended.

Other Tests

  • Pulmonary function tests: Oxygenation is commonly affected in individuals with PAVM. Most patients have saturation levels of less than 90% at rest. Orthodeoxia is a decrease in PaO2 or SaO2 that occurs when one assumes an upright position from the supine position. Patients with this finding have normal spirometric findings and a mildly reduced diffusing capacity. Recent case series have indicated that 80-100% of patients with pulmonary arteriovenous malformations have either a PaO2 of less than 80 mm Hg or an SaO2 of less than 98% on room air.
  • Shunt fraction measurement: The shunt fraction is most accurately assessed by using the 100% oxygen method, which involves the measurement of PaO2 and SaO2 after the patient breathes 100% oxygen for 15-20 minutes. The fraction of cardiac output that shunts right-to-left circulation is elevated in patients with pulmonary arteriovenous malformations; normal values are less than 5%. A shunt fraction of more than 5%, as determined by using the 100% oxygen method, has a sensitivity of 87.5% and a specificity of 71.4%.
  • Exercise testing: Patients with pulmonary arteriovenous malformations have reduced exercise tolerance. In most patients, incremental exercise testing results in decreased saturation. One case series of patients showed that the average maximum oxygen consumption was 61% of the predicted value; saturation decreased from 86% at rest to 73% with peak exercise.

Procedures

  • Right heart catheterization
    • Most patients with pulmonary arteriovenous malformations have normal or low pulmonary arterial pressure. Despite severe oxygen desaturation, the mean pulmonary arterial pressure is low in most patients.
    • Their cardiac output is generally normal to moderately elevated.
    • Patients may develop new pulmonary hypertension or increased baseline pulmonary hypertension after embolization or resection of a large pulmonary arteriovenous malformation.
  • The radionuclide method of shunt calculation is expensive and not routinely available at most hospitals; however, it has several advantages compared with the 100% oxygen method.
    • ABG sampling is not needed.
    • The 100% oxygen method may overestimate intrapulmonary shunt.
    • The radionuclide method is more suitable for shunt measurement during exercise.

More on Arteriovenous Fistulae, Pulmonary

Overview: Arteriovenous Fistulae, Pulmonary
Differential Diagnoses & Workup: Arteriovenous Fistulae, Pulmonary
Treatment & Medication: Arteriovenous Fistulae, Pulmonary
Follow-up: Arteriovenous Fistulae, Pulmonary
Multimedia: Arteriovenous Fistulae, Pulmonary
References
Further Reading

References

  1. Ragsdale JA. Hereditary hemorrhagic telangiectasia: from epistaxis to life-threatening GI bleeding. Gastroenterol Nurs. Jul-Aug 2007;30(4):293-9; quiz 300-1. [Medline].

  2. White RI Jr, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. Dec 1988;169(3):663-9. [Medline].

  3. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. Dec 1994;8(4):345-51. [Medline].

  4. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet. Aug 1992;29(8):527-30. [Medline].

  5. Heutink P, Haitjema T, Breedveld GJ, et al. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet. Dec 1994;31(12):933-6. [Medline].

  6. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. Jun 1996;13(2):189-95. [Medline].

  7. Giordano P, Nigro A, Lenato GM, et al. Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician. J Thromb Haemost. Jun 2006;4(6):1237-45. [Medline].

  8. Tomasian A, Lell M, Currier J, Rahman J, Krishnam MS. Coronary artery to pulmonary artery fistulae with multiple aneurysms: radiological features on dual-source 64-slice CT angiography. Br J Radiol. Sep 2008;81(969):e218-20. [Medline].

  9. Grosso M, Groppo Marchisio F, Testa F, et al. Pulmonary arteriovenous malformations: percutaneous treatment preserving parenchyma in high-flow fistulae. Radiol Med. Apr 2008;113(3):395-413. [Medline].

  10. Ishikawa Y, Yamanaka K, Nishii T, Fujii K, Rino Y, Maehara T. Video-assisted thoracoscopic surgery for pulmonary arteriovenous malformations: report of five cases. Gen Thorac Cardiovasc Surg. Apr 2008;56(4):187-90. [Medline].

  11. Pollak JS, Saluja S, Thabet A, et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol. Jan 2006;17(1):35-44; quiz 45. [Medline].

  12. Bialkowski J, Zabal C, Szkutnik M, et al. Percutaneous interventional closure of large pulmonary arteriovenous fistulas with the amplatzer duct occluder. Am J Cardiol. Jul 1 2005;96(1):127-9. [Medline].

  13. McFaul RC, Tajik AJ, Mair DD, et al. Development of pulmonary arteriovenous shunt after superior vena cava- right pulmonary artery (Glenn) anastomosis. Report of four cases. Circulation. Jan 1977;55(1):212-6. [Medline].

  14. Cloutier A, Ash JM, Smallhorn JF, et al. Abnormal distribution of pulmonary blood flow after the Glenn shunt or Fontan procedure: risk of development of arteriovenous fistulae. Circulation. Sep 1985;72(3):471-9. [Medline].

  15. Laks H, Kaiser GC, Mudd JG, et al. Revascularization of the right coronary artery. Am J Cardiol. Jun 1979;43(6):1109-13. [Medline].

  16. Gomes AS, Benson L, George B, Laks H. Management of pulmonary arteriovenous fistulas after superior vena cava- right pulmonary artery (Glenn) anastomosis. J Thorac Cardiovasc Surg. Apr 1984;87(4):636-9. [Medline].

  17. Allen SW, Whitfield JM, Clarke DR, et al. Pulmonary arteriovenous malformation in the newborn: a familial case. Pediatr Cardiol. Jan 1993;14(1):58-61. [Medline].

  18. Beck A, Dagan T, Matitiau A, Bruckheimer E. Transcatheter closure of pulmonary arteriovenous malformations with Amplatzer devices. Catheter Cardiovasc Interv. Apr 30 2006;67(6):932-937. [Medline].

  19. Borsellino A, Giorlandino C, Malena S, et al. Early neurologic complications of pulmonary arteriovenous malformation in a newborn: an indication for surgical resection. J Pediatr Surg. Feb 2006;41(2):453-5. [Medline].

  20. Chilvers ER, Whyte MK, Jackson JE, et al. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Dis. Aug 1990;142(2):420-5. [Medline].

  21. Dutton JA, Jackson JE, Hughes JM, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol. Nov 1995;165(5):1119-25. [Medline].

  22. Faughnan ME, Lui YW, Wirth JA, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest. Jan 2000;117(1):31-8. [Medline].

  23. Faughnan ME, Thabet A, Mei-Zahav M, et al. Pulmonary arteriovenous malformations in children: outcomes of transcatheter embolotherapy. J Pediatr. Dec 2004;145(6):826-31. [Medline].

  24. Ference BA, Shannon TM, White RI Jr, et al. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest. Nov 1994;106(5):1387-90. [Medline].

  25. Gallitelli M, Guastamacchia E, Resta F, et al. Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Brain Abscess. Respiration. Jul 21 2005;[Medline].

  26. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. Aug 1998;158(2):643-61. [Medline].

  27. Laks H, Williams W, Trusler G, Castaneda A. Subclavian arterioplasty for the ipsilateral subclavian-to-pulmonary artery shunt. Circulation. Aug 1979;60(2 Pt 2):115-9. [Medline].

  28. Lenato GM, Guanti G. Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects. Curr Pharm Des. 2006;12(10):1173-93. [Medline].

  29. Pooyan P, Shah L, Goli S, et al. Post-traumatic thoracic arteriovenous fistulas. Tenn Med. Apr 2005;98(4):181-3. [Medline].

  30. Puskas JD, Allen MS, Moncure AC, et al. Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg. Aug 1993;56(2):253-7; discussion 257-8. [Medline].

  31. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology. Mar 1992;182(3):809-16. [Medline].

  32. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu- Osler-Weber syndrome). Am J Med Genet. Mar 6 2000;91(1):66-7. [Medline].

  33. Sluiter-Eringa H, Orie NG, Sluiter HJ. Pulmonary arteriovenous fistula. Diagnosis and prognosis in noncomplainant patients. Am Rev Respir Dis. Aug 1969;100(2):177-88. [Medline].

  34. Sperling DC, Cheitlin M, Sullivan RW, Smith A. Pulmonary arteriovenous fistulas with pulmonary hypertension. Chest. Jun 1977;71(6):753-7. [Medline].

  35. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc. Jul 1999;74(7):671-80. [Medline].

  36. Ueki J, Hughes JM, Peters AM, et al. Oxygen and 99mTc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: effects of changes in posture and lung volume. Thorax. Apr 1994;49(4):327-31. [Medline].

  37. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand. 1985;218(1):105-9. [Medline].

Further Reading

Keywords

pulmonary arteriovenous fistulae, pulmonary arteriovenous malformation, PAVM, pulmonary AVM, pulmonary arteriovenous fistula, Rendu-Osler-Weber syndrome, Rendu-Osler-Weber disease, Osler disease, Osler's disease, telangiectasia, hereditary hemorrhagic telangiectasia, HHT, arteriovenous malformation, AVM, cirrhosis, schistosomiasis, mitral stenosis, actinomycosis, metastatic thyroid carcinoma, bronchiectasis, cerebrovascular malformations, stroke, brain abscess, iron-deficiency anemia, Fanconi syndrome, diagnosis, treatment

Contributor Information and Disclosures

Author

Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St. Boniface General Hospital
Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Charles I Berul, MD, Associate Professor of Pediatrics, Harvard Medical School; Senior Associate, Department of Cardiology, Children's Hospital of Boston
Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Heart Rhythm Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Alvin J Chin, MD, Professor of Pediatrics, Division of Cardiology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine
Alvin J Chin, MD is a member of the following medical societies: American Association for the Advancement of Science and American Heart Association
Disclosure: Nothing to disclose.

CME Editor

Gilbert Z Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College; Consulting Staff, Department of Pediatrics, Sound Shore Medical Center
Gilbert Z Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Steven R Neish, MD, SM, Director of Pediatric Cardiology Fellowship Program, Associate Professor, Department of Pediatrics, Baylor College of Medicine
Steven R Neish, MD, SM is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and American Heart Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.